These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6418635)

  • 41. Qualitative characteristics of the beta-glucosidase isozymes.
    Choy FY; Davidson RG
    Prog Clin Biol Res; 1982; 95():415-41. PubMed ID: 6812079
    [No Abstract]   [Full Text] [Related]  

  • 42. Heterozygote detection of type I Gaucher disease using blood platelets.
    Nakagawa S; Kumin S; Sachs G; Nitowsky HM
    Clin Chim Acta; 1982 Jan; 118(1):99-107. PubMed ID: 6797762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiple glycosidase deficiencies in a case of juvenile (type 3) Gaucher disease.
    Chiao YB; Hoyson GM; Peters SP; Lee RE; Diven W; Murphy JV; Glew RH
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2448-52. PubMed ID: 27787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple forms of beta-glucosidase in Gaucher disease.
    Yaqoob M; Carroll M
    Prog Clin Biol Res; 1982; 95():453-63. PubMed ID: 6812081
    [No Abstract]   [Full Text] [Related]  

  • 45. Identification and expression of acid beta-glucosidase mutations causing severe type 1 and neurologic type 2 Gaucher disease in non-Jewish patients.
    Grace ME; Desnick RJ; Pastores GM
    J Clin Invest; 1997 May; 99(10):2530-7. PubMed ID: 9153297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrovirus-mediated transfer of the human glucocerebrosidase gene to Gaucher fibroblasts.
    Choudary PV; Barranger JA; Tsuji S; Mayor J; LaMarca ME; Cepko CL; Mulligan RC; Ginns EI
    Mol Biol Med; 1986 Jun; 3(3):293-9. PubMed ID: 3736391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
    Choy FY
    Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. beta-Glucosidase assays in the diagnosis of Gaucher's disease.
    Daniels LB; Glew RH
    Clin Chem; 1982 Apr; 28(4 Pt 1):569-77. PubMed ID: 6804115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A method for enrichment of hybrid somatic cells: complementation studies in certain lysosomal enzymopathies.
    Nelson PV; Carey WF
    J Inherit Metab Dis; 1985; 8(3):95-9. PubMed ID: 3939596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts.
    Aureli M; Bassi R; Loberto N; Regis S; Prinetti A; Chigorno V; Aerts JM; Boot RG; Filocamo M; Sonnino S
    J Inherit Metab Dis; 2012 Nov; 35(6):1081-91. PubMed ID: 22526844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside.
    Barns RJ; Clague AE
    Clin Chim Acta; 1982 Mar; 120(1):57-63. PubMed ID: 7067140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-specific differences in membrane beta-glucosidase from normal and Gaucher cells.
    Turner BM; Beratis NG; Hirschhorn K
    Biochim Biophys Acta; 1977 Feb; 480(2):442-9. PubMed ID: 13844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophoretic separation of neutral and acid beta-glucosidase isozymes in human tissues.
    Shafit-Zagardo B; Devine EA; Desnick RJ
    Biochim Biophys Acta; 1980 Aug; 614(2):459-65. PubMed ID: 6773581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The enzymatic hydrolysis of 6-acylamino-4-methylumbelliferyl-beta-D-glucosides: identification of a novel human acid beta-glucosidase.
    Mikhaylova M; Wiederschain G; Mikhaylov V; Aerts JM
    Biochim Biophys Acta; 1996 Oct; 1317(1):71-9. PubMed ID: 8876629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and use of novel fluorescent glycosphingolipids for estimating beta-glucosidase activity in vitro in the absence of detergents and subtyping Gaucher disease variants following administration into intact cells.
    Agmon V; Cherbu S; Dagan A; Grace M; Grabowski GA; Gatt S
    Biochim Biophys Acta; 1993 Sep; 1170(1):72-9. PubMed ID: 8399329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modification of subunit interaction in membrane-bound acid beta-glucosidase from Gaucher disease.
    Maret A; Potier M; Salvayre R; Douste-Blazy L
    FEBS Lett; 1983 Aug; 160(1-2):93-7. PubMed ID: 6411492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transgenic mice expressing human glucocerebrosidase variants: utility for the study of Gaucher disease.
    Sanders A; Hemmelgarn H; Melrose HL; Hein L; Fuller M; Clarke LA
    Blood Cells Mol Dis; 2013 Aug; 51(2):109-15. PubMed ID: 23642305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chromosomal localization of the gene for Gaucher disease.
    Devine EA; Smith M; Arredondo-Vega FX; Shafit-Zagardo B; Desnick RJ
    Prog Clin Biol Res; 1982; 95():511-34. PubMed ID: 6812085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical properties of beta-glucosidase in leukocytes from patients and obligated heterozygotes for Gaucher disease carriers.
    Michelin K; Wajner A; Bock H; Fachel A; Rosenberg R; Pires RF; Pereira ML; Giugliani R; Coelho JC
    Clin Chim Acta; 2005 Dec; 362(1-2):101-9. PubMed ID: 16039637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.